» Articles » PMID: 28706520

Hypothermia Promotes Interleukin-22 Expression and Fine-Tunes Its Biological Activity

Overview
Journal Front Immunol
Date 2017 Jul 15
PMID 28706520
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Disturbed homeostasis as a result of tissue stress can provoke leukocyte responses enabling recovery. Since mild hypothermia displays specific clinically relevant tissue-protective properties and interleukin (IL)-22 promotes healing at host/environment interfaces, effects of lowered ambient temperature on IL-22 were studied. We demonstrate that a 5-h exposure of endotoxemic mice to 4°C reduces body temperature by 5.0° and enhances splenic and colonic gene expression. In contrast, tumor necrosis factor-α and IL-17A were not increased. data on IL-22 were corroborated using murine splenocytes and human peripheral blood mononuclear cells (PBMC) cultured upon 33°C and polyclonal T cell activation. Upregulation by mild hypothermia of largely T-cell-derived IL-22 in PBMC required monocytes and associated with enhanced nuclear T-cell nuclear factor of activated T cells (NFAT)-c2. Notably, NFAT antagonism by cyclosporin A or FK506 impaired IL-22 upregulation at normothermia and entirely prevented its enhanced expression upon hypothermic culture conditions. Data suggest that intact NFAT signaling is required for efficient IL-22 induction upon normothermic and hypothermic conditions. Hypothermia furthermore boosted early signal transducer and activator of transcription 3 activation by IL-22 and shaped downstream gene expression in epithelial-like cells. Altogether, data indicate that hypothermia supports and fine-tunes IL-22 production/action, which may contribute to regulatory properties of low ambient temperature.

Citing Articles

CD14CD16 monocytes are the main producers of Interleukin-10 following clinical heart transplantation.

Ludwig K, Chichelnitskiy E, Kuhne J, Wiegmann B, Iske J, Ledwoch N Front Immunol. 2023; 14:1257526.

PMID: 37936714 PMC: 10627027. DOI: 10.3389/fimmu.2023.1257526.


Composition of perfusion solutions and kinetics define differential cytokine/chemokine secretion in a porcine cardiac arrest model of lung preservation.

Radomsky L, Koch A, Olbertz C, Liu Y, Beushausen K, Keil J Front Cardiovasc Med. 2023; 10:1245618.

PMID: 37808880 PMC: 10556242. DOI: 10.3389/fcvm.2023.1245618.


A Tangled Threesome: Circadian Rhythm, Body Temperature Variations, and the Immune System.

Coiffard B, Diallo A, Mezouar S, Leone M, Mege J Biology (Basel). 2021; 10(1).

PMID: 33477463 PMC: 7829919. DOI: 10.3390/biology10010065.

References
1.
Rutz S, Eidenschenk C, Ouyang W . IL-22, not simply a Th17 cytokine. Immunol Rev. 2013; 252(1):116-32. DOI: 10.1111/imr.12027. View

2.
Hasnain S, Borg D, Harcourt B, Tong H, Sheng Y, Ng C . Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress. Nat Med. 2014; 20(12):1417-26. DOI: 10.1038/nm.3705. View

3.
Du G, Liu Y, Li J, Liu W, Wang Y, Li H . Hypothermic microenvironment plays a key role in tumor immune subversion. Int Immunopharmacol. 2013; 17(2):245-53. DOI: 10.1016/j.intimp.2013.06.018. View

4.
Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, Wolk K . Biology of interleukin-10. Cytokine Growth Factor Rev. 2010; 21(5):331-44. DOI: 10.1016/j.cytogfr.2010.09.002. View

5.
Paulukat J, Bosmann M, Nold M, Garkisch S, Kampfer H, Frank S . Expression and release of IL-18 binding protein in response to IFN-gamma. J Immunol. 2001; 167(12):7038-43. DOI: 10.4049/jimmunol.167.12.7038. View